IDEXX Laboratories, Inc.
IDXX
$430.12
$1.090.25%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.18% | -2.79% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.18% | -2.79% | |||
| Cost of Revenue | 1.09% | -1.28% | |||
| Gross Profit | -4.26% | -3.73% | |||
| SG&A Expenses | 42.21% | -25.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.51% | -10.04% | |||
| Operating Income | -28.38% | 12.32% | |||
| Income Before Tax | -14.23% | 15.38% | |||
| Income Tax Expenses | -39.10% | 18.49% | |||
| Earnings from Continuing Operations | -7.17% | 14.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.17% | 14.53% | |||
| EBIT | -28.38% | 12.32% | |||
| EBITDA | -26.06% | 11.76% | |||
| EPS Basic | -6.65% | 14.99% | |||
| Normalized Basic EPS | -28.47% | 12.88% | |||
| EPS Diluted | -6.44% | 14.75% | |||
| Normalized Diluted EPS | -28.42% | 12.89% | |||
| Average Basic Shares Outstanding | -0.56% | -0.39% | |||
| Average Diluted Shares Outstanding | -0.62% | -0.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
